| Name | 3-(4-phenylpiperazin-1-yl)propane-1,2-diol |
|---|---|
| Synonyms |
(±)-Dropropizine|||UCB-196|||UCB-1967
(+/-)-DROPROPIZINE UCB-196 Tussilex ribex 1-(2,3-Dihydroxypropyl)-4-phenylpiperazine EINECS 241-683-7 Dropropizine, 10 mM in DMSO lylin (-Dropropizine 1-Phenyl-4-(2,3-dihydroxypropyl)diethylenediamine Dipropizine MFCD00079124 (+-)-dropropizine katril UCB-1967 3-(4-Phenyl-1-piperazinyl)-1,2-pmpanediol DROPROPIZINE Dopropizin 1,2-PROPANEDIOL, 3-(4-PHENYL-1-PIPERAZINYL) 3-(4-phenyl-1-piperazinyl)propane-1,2-diol Catabex levodropropizine 3-(4-Phenyl-1-piperazinyl)-1,2-propanediol Katril gevotuss 3-(4-Phenyl-1-piperazinyl)1,2 ditustat dopropizin Dropropizine ISO 9001:2015 REACH (+-)-Dropropizine Ribex Larylin Ditustat 1-Phenyl-4-(2,3-dihydroxypropyl)piperazine 3-(4-phenyl-1-piperazinyl)-2-propanediol rac Dropropizine LABOTEST-BB LT00771927 tussilex catabex dipropizine 3-[4-PHENYL-1-PIPERAZINYL]-1,2-PROPANEDIOL |
| Description | Dropropizine is a racemic non-opiate antitussive agent which has been used clinically for many years. |
|---|---|
| Related Catalog |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 412.7±34.0 °C at 760 mmHg |
| Melting Point | 105-108ºC |
| Molecular Formula | C13H20N2O2 |
| Molecular Weight | 236.310 |
| Flash Point | 220.9±24.3 °C |
| Exact Mass | 236.152481 |
| PSA | 46.94000 |
| LogP | 0.46 |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.577 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xn:Harmful; |
| Risk Phrases | R22 |
| Safety Phrases | S36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | TZ1074800 |
| HS Code | 2933599090 |
|
~%
17692-31-8 |
| Literature: Tetrahedron Letters, , vol. 33, # 22 p. 3231 - 3234 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |